Analytical issues on prostate-specific antigen in relation to prostate cancer screening
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Biochemistry
- Vol. 31 (8) , 633-639
- https://doi.org/10.1016/s0009-9120(98)00072-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Evaluation of prostate‐specific antigen, digital rectal examination and transrectal ultrasonography in population‐based screening for prostate cancer: improving the efficiency of early detectionBritish Journal of Urology, 1997
- In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samplesUrology, 1996
- Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening populationUrology, 1996
- The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA densityUrology, 1995
- Geographical and temporal patterns of incidence and mortality from prostate cancerUrology, 1995
- Prostate cancer screening and prevention: “realities and hope”Urology, 1995
- Second stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994Urology, 1995
- Quality Control and Standardization of Tumour Marker TestsTumor Biology, 1993
- Modalities available for screening for prostate cancerEuropean Journal Of Cancer, 1993
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986